CORRECTION article

Front. Pharmacol., 14 November 2022

Sec. Predictive Toxicology

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1079635

Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes

  • 1. Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China

  • 2. Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, China

Article metrics

View details

2

Citations

1,5k

Views

661

Downloads

In the published article, there was an error in the Author list and Correspondence section, and authors Hongjiang Song and Xingrui Li were inserted in the wrong order. The corrected Author list and Correspondence section appear below.

“Li Chen, Hao Sun, Ruihu Zhao, Rong Huang, Hongming Pan, Yanjiao Zuo, Lele Zhang, Yingwei Xue, Hongjiang Song and Xingrui Li.”

“*Correspondence: Hongjiang Song, ; Xingrui Li, .”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

gastric cancer, controlling nutritional status, immune checkpoint inhibitors, PD-1, PD-L1

Citation

Chen L, Sun H, Zhao R, Huang R, Pan H, Zuo Y, Zhang L, Xue Y, Song H and Li X (2022) Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes. Front. Pharmacol. 13:1079635. doi: 10.3389/fphar.2022.1079635

Received

25 October 2022

Accepted

26 October 2022

Published

14 November 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Hongjiang Song, ; Xingrui Li,

†ORCID: Li Chen, 0000-0002-6989-1177

‡These authors have contributed equally to this work

This article was submitted to Predictive Toxicology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics